Patents by Inventor David Arthur Berry

David Arthur Berry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100330155
    Abstract: The present invention relates to chemically modified, linked double-stranded (ds)RNA compositions comprising two or more double-stranded (ds) oligoribonucleotides linked by at least one linking moiety and methods of formulating and delivering such compositions to modulate gene expression through target-specific RNA co-interference (RNAco-i). The compositions of the invention may optionally comprise a conjugation or a complex with one or more small molecule drugs, protein therapeutics, or other dsRNA molecules. The present invention is directed at the methods of production for, methods of use of, and therapeutic utilities for RNAi co-interference therapy utilizing the compositions of the invention.
    Type: Application
    Filed: January 19, 2010
    Publication date: December 30, 2010
    Applicant: FLAGSHIP VENTURES
    Inventors: David Arthur Berry, Noubar Boghos Afeyan, Chris Varma
  • Patent number: 7785861
    Abstract: The present disclosure identifies pathways and mechanisms to confer improved industrial fitness on engineered organisms. It also discloses engineered organisms having improved industrial fitness. Synthetic biologic engineering modules are disclosed that provide for light capture, carbon dioxide fixation, NADH production, NADPH production, thermotolerance, pH tolerance, flue gas tolerance, salt tolerance, nutrient independence and near infrared absorbance. The disclosed engineered organisms can include one or more of these modules. Also provided are methods of using the engineered organism to produce carbon-based products of interest, biomass or pharmaceutical agents.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: August 31, 2010
    Assignee: Joule Unlimited, Inc.
    Inventors: Eric James Devroe, Sriram Kosuri, David Arthur Berry, Noubar Boghos Afeyan, Frank Anthony Skraly, Dan Eric Robertson, Brian Green, Christian Perry Ridley
  • Publication number: 20090203070
    Abstract: The present disclosure identifies pathways and mechanisms to confer improved industrial fitness on engineered organisms. It also discloses engineered organisms having improved industrial fitness. Synthetic biologic engineering modules are disclosed that provide for light capture, carbon dioxide fixation, NADH production, NADPH production, thermotolerance, pH tolerance, flue gas tolerance, salt tolerance, nutrient independence and near infrared absorbance. The disclosed engineered organisms can include one or more of these modules. Also provided are methods of using the engineered organism to produce carbon-based products of interest, biomass or pharmaceutical agents.
    Type: Application
    Filed: November 10, 2008
    Publication date: August 13, 2009
    Applicant: JOULE BIOTECHNOLOGIES, INC.
    Inventors: Eric James Devroe, Sriram Kosuri, David Arthur Berry, Noubar Boghos Afeyan, Frank Anthony Skraly, Dan Eric Robertson, Brian Green, Christian Perry Ridley
  • Publication number: 20090191599
    Abstract: The present disclosure identifies pathways and mechanisms to confer photoautotrophic properties to a heterotrophic organism. The resultant engineered cell or organism will uniquely enable efficient conversion of carbon dioxide and light into biomass and carbon-based products of interest.
    Type: Application
    Filed: September 10, 2008
    Publication date: July 30, 2009
    Applicant: Joule Biotechnologies, Inc.
    Inventors: Eric James Devroe, David Arthur Berry, Noubar Boghos Afeyan, Dan Eric Robertson, Frank Anthony Skraly, Christian Perry Ridley
  • Publication number: 20080311040
    Abstract: The present invention relates to chemically modified, linked double-stranded (ds)RNA compositions comprising two or more double-stranded (ds) oligoribonucleotides linked by at least one linking moiety and methods of formulating and delivering such compositions to modulate gene expression through target-specific RNA co-interference (RNAco-i). The compositions of the invention may optionally comprise a conjugation or a complex with one or more small molecule drugs, protein therapeutics, or other dsRNA molecules. The present invention is directed at the methods of production for, methods of use of, and therapeutic utilities for RNAi co-interference therapy utilizing the compositions of the invention.
    Type: Application
    Filed: March 5, 2008
    Publication date: December 18, 2008
    Applicant: Flagship Ventures
    Inventors: David Arthur Berry, Noubar Boghes Afeyan, Chris Varma